View in EDS PDF Full Text

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.

Saved in:
Bibliographic Details
Title: Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.
Authors: Imafuku T; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.; Lipid Metabolism Unit, Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA., Watanabe H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan hnabe@kumamoto-u.ac.jp tomaru@gpo.kumamoto-u.ac.jp., Oniki K; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Yoshida A; Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan., Kato H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Nakano T; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Tokumaru K; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Fujita I; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Arimura N; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Maeda H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Sakamoto Y; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Kondo N; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Morita A; Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan., Saruwatari J; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Tanaka M; Department of Nephrology, Akebono Clinic, Kumamoto, Japan., Matsushita K; Department of Nephrology, Akebono Clinic, Kumamoto, Japan., Wada T; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan., Fukagawa M; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Kanagawa, Japan., Otagiri M; Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan., Fitzgerald ML; Lipid Metabolism Unit, Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA., Jinnouchi H; Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan., Maruyama T; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan hnabe@kumamoto-u.ac.jp tomaru@gpo.kumamoto-u.ac.jp.
Source: Diabetes care [Diabetes Care] 2021 Jun; Vol. 44 (6), pp. e115-e117. Date of Electronic Publication: 2021 Apr 26.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33905348
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Imafuku+T%22">Imafuku T</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.; Lipid Metabolism Unit, Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Watanabe+H%22">Watanabe H</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan hnabe@kumamoto-u.ac.jp tomaru@gpo.kumamoto-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Oniki+K%22">Oniki K</searchLink>; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+A%22">Yoshida A</searchLink>; Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Kato+H%22">Kato H</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Nakano+T%22">Nakano T</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Tokumaru+K%22">Tokumaru K</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+I%22">Fujita I</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Arimura+N%22">Arimura N</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Maeda+H%22">Maeda H</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Sakamoto+Y%22">Sakamoto Y</searchLink>; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Kondo+N%22">Kondo N</searchLink>; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Morita+A%22">Morita A</searchLink>; Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Saruwatari+J%22">Saruwatari J</searchLink>; Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+M%22">Tanaka M</searchLink>; Department of Nephrology, Akebono Clinic, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Matsushita+K%22">Matsushita K</searchLink>; Department of Nephrology, Akebono Clinic, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Wada+T%22">Wada T</searchLink>; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.<br /><searchLink fieldCode="AU" term="%22Fukagawa+M%22">Fukagawa M</searchLink>; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Otagiri+M%22">Otagiri M</searchLink>; Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+ML%22">Fitzgerald ML</searchLink>; Lipid Metabolism Unit, Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Jinnouchi+H%22">Jinnouchi H</searchLink>; Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Maruyama+T%22">Maruyama T</searchLink>; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan hnabe@kumamoto-u.ac.jp tomaru@gpo.kumamoto-u.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227805975%22">Diabetes care</searchLink> [Diabetes Care] 2021 Jun; Vol. 44 (6), pp. e115-e117. <i>Date of Electronic Publication: </i>2021 Apr 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7805975 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-5548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201495992%22">01495992 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Care <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33905348
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2337/dc20-3003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e115
    Titles:
      – TitleFull: Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Imafuku T
      – PersonEntity:
          Name:
            NameFull: Watanabe H
      – PersonEntity:
          Name:
            NameFull: Oniki K
      – PersonEntity:
          Name:
            NameFull: Yoshida A
      – PersonEntity:
          Name:
            NameFull: Kato H
      – PersonEntity:
          Name:
            NameFull: Nakano T
      – PersonEntity:
          Name:
            NameFull: Tokumaru K
      – PersonEntity:
          Name:
            NameFull: Fujita I
      – PersonEntity:
          Name:
            NameFull: Arimura N
      – PersonEntity:
          Name:
            NameFull: Maeda H
      – PersonEntity:
          Name:
            NameFull: Sakamoto Y
      – PersonEntity:
          Name:
            NameFull: Kondo N
      – PersonEntity:
          Name:
            NameFull: Morita A
      – PersonEntity:
          Name:
            NameFull: Saruwatari J
      – PersonEntity:
          Name:
            NameFull: Tanaka M
      – PersonEntity:
          Name:
            NameFull: Matsushita K
      – PersonEntity:
          Name:
            NameFull: Wada T
      – PersonEntity:
          Name:
            NameFull: Fukagawa M
      – PersonEntity:
          Name:
            NameFull: Otagiri M
      – PersonEntity:
          Name:
            NameFull: Fitzgerald ML
      – PersonEntity:
          Name:
            NameFull: Jinnouchi H
      – PersonEntity:
          Name:
            NameFull: Maruyama T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2021 Jun
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1935-5548
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Diabetes care
              Type: main
ResultId 1